Silverback Therapeutics (SBTX) News Today

$5.21

+0.26 (+5.25%)

(As of 12/4/2023 ET)

Compare

Today's Range: $4.94
▼
$5.21
50-Day Range: $3.38
▼
$5.21
52-Week Range: $2.80
▼
$8.97

Volume: 731,988 shs
Average Volume: 337,931 shs
Market Capitalization: $187.86 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Headlines Insider Trades Ownership SEC Filings Social Media

Source

Source	Headline
	Royce & Associates LP Invests $1.98 Million in Silverback Therapeutics, Inc. (NASDAQ:SBTX) marketbeat.com - September 13 at 10:43 AM
	SR One Capital Management LP Purchases 1,003,226 Shares of Silverback Therapeutics, Inc. (NASDAQ:SBTX) marketbeat.com - August 11 at 5:39 PM
	Levin Capital Strategies L.P. Boosts Stake in Silverback Therapeutics, Inc. (NASDAQ:SBTX) marketbeat.com - July 7 at 12:28 PM
	Vontobel Holding Ltd. Raises Holdings in Silverback Therapeutics, Inc. (NASDAQ:SBTX) marketbeat.com - June 29 at 4:35 AM
	Citigroup Inc. Boosts Stock Holdings in Silverback Therapeutics, Inc. (NASDAQ:SBTX) marketbeat.com - June 2 at 5:16 AM
	Silverback Therapeutics, Inc. (NASDAQ:SBTX) Shares Sold by K2 Principal Fund L.P. marketbeat.com - May 26 at 2:51 PM
	ARS Pharmaceuticals Inc (SPRY) uk.investing.com - May 11 at 1:32 PM
	Ergoteles LLC Has $394,000 Stock Position in Silverback Therapeutics, Inc. (NASDAQ:SBTX) marketbeat.com - March 3 at 5:33 AM
	Rubric Capital Management LP Has $14.23 Million Stock Position in Silverback Therapeutics, Inc. (NASDAQ:SBTX) marketbeat.com - February 17 at 11:48 AM
	SPRY ARS Pharmaceuticals, Inc. seekingalpha.com - January 24 at 8:04 PM
	ARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After Merger 247wallst.com - November 22 at 6:29 AM
	Dr. Sarina Tanimoto Discloses Position in SBTX / Silverback Therapeutics nasdaq.com - November 18 at 8:19 PM
	ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis finance.yahoo.com - November 10 at 6:41 PM
	ARS Pharmaceuticals Closes Merger with Silverback Therapeutics finance.yahoo.com - November 8 at 5:59 PM
	Silverback : FDA Accepts ARS Pharm's NDA For Neffy For Treatment Of Allergic Reactions markets.businessinsider.com - October 28 at 8:15 AM
	Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis finance.yahoo.com - October 21 at 7:59 AM
	Silverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Up 83.5% in September marketbeat.com - October 14 at 7:19 PM
	INVESTIGATION ALERT: Halper Sadeh LLC Investigates CVET, SBTX, IRBT markets.businessinsider.com - September 17 at 5:10 AM
	SBTX Silverback Therapeutics, Inc. seekingalpha.com - September 15 at 10:58 PM
	SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT markets.businessinsider.com - September 6 at 11:53 AM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY markets.businessinsider.com - August 23 at 6:32 PM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTX apnews.com - August 17 at 12:02 PM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates IEA, BBQ, SBTX apnews.com - August 11 at 1:33 AM
	Silverback Therapeutics, Inc. (NASDAQ:SBTX) Sees Significant Decrease in Short Interest marketbeat.com - July 31 at 2:50 AM
	SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations morningstar.com - July 30 at 7:00 AM
	INVESTIGATION ALERT: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY apnews.com - July 28 at 2:21 AM
	Shareholder Alert - The M&A Class Action Firm Announces the Investigation of Silverback Therapeutics, Inc. - SBTX benzinga.com - July 27 at 9:21 PM
	Lifshitz Law PLLC Announces Investigation of IEA, ZY, SBTX, and HNGR apnews.com - July 26 at 9:07 PM
	Silverback Therapeutics plans merger with San Diego biotech finance.yahoo.com - July 26 at 11:07 AM
	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HNGR, SBTX, U apnews.com - July 25 at 1:43 PM
	SILVERBACK THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of SBTX and Encourages Investors to Contact the Firm benzinga.com - July 22 at 11:04 PM
	SHAREHOLDER ALERT: Weiss Law Investigates Silverback Therapeutics, Inc. prnewswire.com - July 22 at 8:30 PM
	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HNGR, ONEM, SBTX, ZEN apnews.com - July 22 at 1:04 PM
	Once A Cancer Company, Silverback Merges With Small Biotech Working On Allergy Treatment finance.yahoo.com - July 22 at 1:04 PM
	Silverback Therapeutics Shares Down After Merger News marketwatch.com - July 22 at 8:03 AM
	Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative msn.com - July 22 at 8:03 AM
	SBTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Silverback Therapeutics, Inc. Is Fair to Shareholders benzinga.com - July 21 at 9:02 PM
	Silverback Therapeutics and ARS Pharmaceuticals Announce Merger finance.yahoo.com - July 21 at 9:02 PM
	Silverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Down 32.4% in June marketbeat.com - July 17 at 5:03 AM
	What You Need To Know About Silverback Therapeutics, Inc.'s (NASDAQ:SBTX) Investor Composition finance.yahoo.com - June 22 at 4:28 PM
	Silverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Down 16.5% in May marketbeat.com - June 17 at 7:17 AM
	Silverback Therapeutics (NASDAQ:SBTX) Stock Rating Lowered by Zacks Investment Research marketbeat.com - June 1 at 5:01 AM
	Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com - May 17 at 4:11 PM
	Silverback Therapeutics, Inc. (NASDAQ:SBTX) Short Interest Up 35.2% in April marketbeat.com - May 16 at 8:36 AM
	Silverback Therapeutics (NASDAQ:SBTX) Price Target Cut to $5.00 by Analysts at Stifel Nicolaus marketbeat.com - May 13 at 4:00 PM
	Silverback Therapeutics GAAP EPS of -$0.70 misses by $0.03 seekingalpha.com - May 12 at 5:40 PM
	Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - May 12 at 5:40 PM
	Is Silverback Therapeutics (NASDAQ:SBTX) In A Good Position To Deliver On Growth Plans? finance.yahoo.com - May 8 at 1:23 PM
	Silverback Therapeutics (NASDAQ:SBTX) Upgraded to "Buy" at Zacks Investment Research marketbeat.com - April 6 at 6:19 AM
	Goldman Sachs Downgrades Silverback Therapeutics to Neutral, Lowers Price Target to $3.5 benzinga.com - April 4 at 10:02 AM

Get Silverback Therapeutics News Delivered to You Automatically

SBTX Media Mentions By Week

SBTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SBTX
News Sentiment
▼
0.00

0.70
▲
Average
Medical
News Sentiment

SBTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SBTX Articles
This Week
▼
0

0
▲
SBTX Articles
Average Week

Get Silverback Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:SBTX) was last updated on 12/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Silverback Therapeutics (SBTX) News Today

SBTX Media Mentions By Week

SBTX Media Sentiment

SBTX News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info